CV Lattes
Universidade de São Paulo (USP). Instituto de Química (IQ) (Institutional affiliation from the last research proposal) Birthplace: Brazil
In 2013, worked in a research project on the investigation of Aurora A and Aurora B kinases as potential therapeutic targets in KRAS-induced lung cancer at the Laboratory of Molecular Biology of Cancer (University of São Paulo, Chemistry Institute). Has experience in Collective Health, focusing on Public Health and Social Control, researching how much people might know about the Management Councils of their local Basic Health Units. Fernando worked on a project that wants to understand the role of the inhibition of tumor supressor gene FOXO1 in lung cancer oncogenesis mediated by mutations in KRAS. Fernando has also been the president of Liga de Combate a Febre Reumatica, a student organization that aims to provide healthcare to patients that suffer from rheumatic heart disease. Nowadays, Fernando takes the Molecular and Integrative Physiological Sciences Program course at Harvard T.H. Chan School of Public Health and acts as a researcher at Beth Israel Deaconess Medical Center. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Lung cancer is the deadliest type of cancer. By analyzing genetic variations in lung neoplasms, we notice that point mutations in the proto-oncogene KRAS are the most frequent ones, being identified in nearly 33% of all cases of lung adenocarcinoma. Due to the notable causative effect of activating point-mutations of the KRAS gene, many studies have tried to directly inhibit the action of…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |